This presentation will discuss the prevalence and clinical implications of stroke in long term care. Pivotal clinical trials for secondary prevention of non-cardioembolic stroke using antithrombotic therapy will be reviewed, as will the American Stroke Association and AMDA clinical practice guidelines on Stroke Prevention and Management. Case studies will be utilized to illustrate typical management dilemmas in long term care and, to provide a focus for evidence-based selection of pharmacotherapeutic agents.
Recognize the prevalence and health implications of stroke in the long-term care elderly
Describe the pivotal clinical trials that form the basis of the guideline recommendations
Discuss options for the appropriate use of anticoagulants, antiplatelet, and other antithrombotic agents, based on the 2006 AHA and American Stroke Association Guidelines
Compare the American Heart Association and American Stroke Association Guideline recommendations to current practices in LTC and the AMDA guidelines
Identify interdisciplinary opportunities for appropriate medication management that addresses risk factor